ID RBM19_HUMAN Reviewed; 960 AA. AC Q9Y4C8; Q9BPY6; Q9UFN5; DT 21-FEB-2001, integrated into UniProtKB/Swiss-Prot. DT 05-OCT-2010, sequence version 3. DT 05-OCT-2010, entry version 96. DE RecName: Full=Probable RNA-binding protein 19; DE AltName: Full=RNA-binding motif protein 19; GN Name=RBM19; Synonyms=KIAA0682; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS GLU-602; ARG-609; RP THR-623 AND ALA-665. RC TISSUE=Brain; RX MEDLINE=98403880; PubMed=9734811; DOI=10.1093/dnares/5.3.169; RA Ishikawa K., Nagase T., Suyama M., Miyajima N., Tanaka A., Kotani H., RA Nomura N., Ohara O.; RT "Prediction of the coding sequences of unidentified human genes. X. RT The complete sequences of 100 new cDNA clones from brain which can RT code for large proteins in vitro."; RL DNA Res. 5:169-176(1998). RN [2] RP SEQUENCE REVISION TO N-TERMINUS. RA Ohara O., Suyama M., Nagase T., Ishikawa K.; RL Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS GLU-602 AND RP GLN-921. RC TISSUE=Uterus; RX MEDLINE=21154917; PubMed=11230166; DOI=10.1101/gr.GR1547R; RA Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S., RA Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., RA Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N., RA Mewes H.-W., Ottenwaelder B., Obermaier B., Tampe J., Heubner D., RA Wambutt R., Korn B., Klein M., Poustka A.; RT "Towards a catalog of human genes and proteins: sequencing and RT analysis of 500 novel complete protein coding human cDNAs."; RL Genome Res. 11:422-435(2001). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16541075; DOI=10.1038/nature04569; RA Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y., RA Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C., RA Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., RA Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L., RA Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B., RA Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., RA Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z., RA Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z., RA Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H., RA Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H., RA Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., RA Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J., RA Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A., RA Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M., RA Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E., RA Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K., RA Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D., RA Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., RA Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R., RA Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., RA Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C., RA Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M., RA Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M., RA Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P., RA Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L., RA Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E., RA Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C., RA Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F., RA Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M., RA Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S., RA Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J., RA Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A., RA Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M., RA Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I., RA Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A., RA Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., RA Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., RA Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T., RA Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S., RA Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D., RA Kucherlapati R., Weinstock G., Gibbs R.A.; RT "The finished DNA sequence of human chromosome 12."; RL Nature 440:346-351(2006). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS GLU-602; ARG-609; RP THR-623 AND ALA-665. RC TISSUE=Lymph; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA RT project: the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS], AND MASS SPECTROMETRY. RC TISSUE=Cervix carcinoma; RX MEDLINE=22317277; PubMed=12429849; DOI=10.1091/mbc.E02-05-0271; RA Scherl A., Coute Y., Deon C., Calle A., Kindbeiter K., Sanchez J.-C., RA Greco A., Hochstrasser D.F., Diaz J.-J.; RT "Functional proteomic analysis of human nucleolus."; RL Mol. Biol. Cell 13:4100-4109(2002). RN [7] RP SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY. RX PubMed=16027046; DOI=10.1016/j.modgep.2005.05.001; RA Lorenzen J.A., Bonacci B.B., Palmer R.E., Wells C., Zhang J., RA Haber D.A., Goldstein A.M., Mayer A.N.; RT "Rbm19 is a nucleolar protein expressed in crypt/progenitor cells of RT the intestinal epithelium."; RL Gene Expr. Patterns 6:45-56(2005). RN [8] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-949; SER-951 AND RP THR-957, AND MASS SPECTROMETRY. RC TISSUE=Cervix carcinoma; RX PubMed=17081983; DOI=10.1016/j.cell.2006.09.026; RA Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., RA Mann M.; RT "Global, in vivo, and site-specific phosphorylation dynamics in RT signaling networks."; RL Cell 127:635-648(2006). RN [9] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-174; SER-176 AND RP SER-180, AND MASS SPECTROMETRY. RC TISSUE=Cervix carcinoma; RX PubMed=18669648; DOI=10.1073/pnas.0805139105; RA Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., RA Elledge S.J., Gygi S.P.; RT "A quantitative atlas of mitotic phosphorylation."; RL Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). RN [10] RP STRUCTURE BY NMR OF 291-373. RG RIKEN structural genomics initiative (RSGI); RT "Solution structure of the second RNA recognition motif in RNA-binding RT protein 19."; RL Submitted (SEP-2006) to the PDB data bank. CC -!- FUNCTION: Plays a role in embryo pre-implantation development (By CC similarity). CC -!- SUBCELLULAR LOCATION: Nucleus, nucleolus. Nucleus, nucleoplasm (By CC similarity). Cytoplasm (By similarity). Chromosome (By CC similarity). Note=In discrete foci distributed throughout the CC cytoplasm and nucleoplasm during the 4 to 8 cell stages and the CC morula stage, but not in the periphery of the nucleolar precursor CC body (NPB). During blastocyst development, becomes increasingly CC localized to the nucleolus and less to the cytoplasm. At the late CC blastocyst stage, localized predominantly in the nucleolus. CC Localized in the nucleolus during interphase and to the CC perichromosomal sheath during mitosis. Does not colocalize in the CC cytoplasm with GW182 in P-bodies. May translocate to the nucleolus CC upon early embryonic development (By similarity). Colocalizes with CC NPM1 during interphase. By late prophase, metaphase, anaphase and CC telophase, associates with the chromosome periphery. By telophase CC localizes to NPB. CC -!- TISSUE SPECIFICITY: Expressed in the crypts of Lieberkuhn of the CC intestine and in intestinal neoplasia (at protein level). CC -!- SIMILARITY: Belongs to the RRM MRD1 family. CC -!- SIMILARITY: Contains 6 RRM (RNA recognition motif) domains. CC -!- SEQUENCE CAUTION: CC Sequence=BAA31657.2; Type=Erroneous initiation; Note=Translation N-terminally shortened; CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; AB014582; BAA31657.2; ALT_INIT; mRNA. DR EMBL; AL117547; CAB55987.1; -; mRNA. DR EMBL; AC009731; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC073863; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AC090669; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC004289; AAH04289.1; -; mRNA. DR EMBL; BC006137; AAH06137.1; -; mRNA. DR IPI; IPI00000686; -. DR PIR; T17297; T17297. DR RefSeq; NP_001140170.1; -. DR RefSeq; NP_057280.2; -. DR UniGene; Hs.7482; -. DR PDB; 2DGW; NMR; -; A=291-368. DR PDBsum; 2DGW; -. DR ProteinModelPortal; Q9Y4C8; -. DR SMR; Q9Y4C8; 295-479, 403-810, 587-913, 824-918. DR MINT; MINT-1196129; -. DR STRING; Q9Y4C8; -. DR PhosphoSite; Q9Y4C8; -. DR SWISS-2DPAGE; Q9Y4C8; -. DR PRIDE; Q9Y4C8; -. DR Ensembl; ENST00000261741; ENSP00000261741; ENSG00000122965. DR Ensembl; ENST00000392561; ENSP00000376344; ENSG00000122965. DR GeneID; 9904; -. DR KEGG; hsa:9904; -. DR CTD; 9904; -. DR GeneCards; GC12M114259; -. DR HGNC; HGNC:29098; RBM19. DR PharmGKB; PA134886784; -. DR eggNOG; prNOG12426; -. DR HOGENOM; HBG412223; -. DR HOVERGEN; HBG055637; -. DR InParanoid; Q9Y4C8; -. DR PhylomeDB; Q9Y4C8; -. DR NextBio; 37345; -. DR ArrayExpress; Q9Y4C8; -. DR Bgee; Q9Y4C8; -. DR CleanEx; HS_RBM19; -. DR Genevestigator; Q9Y4C8; -. DR GermOnline; ENSG00000122965; Homo sapiens. DR GO; GO:0005694; C:chromosome; IEA:UniProtKB-KW. DR GO; GO:0005737; C:cytoplasm; ISS:UniProtKB. DR GO; GO:0005730; C:nucleolus; IDA:UniProtKB. DR GO; GO:0005654; C:nucleoplasm; ISS:UniProtKB. DR GO; GO:0000166; F:nucleotide binding; IEA:InterPro. DR GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW. DR GO; GO:0007275; P:multicellular organismal development; IEA:UniProtKB-KW. DR GO; GO:0040019; P:positive regulation of embryonic development; ISS:UniProtKB. DR InterPro; IPR012677; a_b_plait_nuc-bd. DR InterPro; IPR000504; RRM_RNP1. DR Gene3D; G3DSA:3.30.70.330; a_b_plait_nuc_bd; 6. DR Pfam; PF00076; RRM_1; 5. DR SMART; SM00360; RRM; 6. DR PROSITE; PS50102; RRM; 6. PE 1: Evidence at protein level; KW 3D-structure; Chromosome; Complete proteome; Cytoplasm; KW Developmental protein; Nucleus; Phosphoprotein; Polymorphism; Repeat; KW RNA-binding. FT CHAIN 1 960 Probable RNA-binding protein 19. FT /FTId=PRO_0000081781. FT DOMAIN 2 79 RRM 1. FT DOMAIN 294 369 RRM 2. FT DOMAIN 402 480 RRM 3. FT DOMAIN 587 659 RRM 4. FT DOMAIN 730 811 RRM 5. FT DOMAIN 832 912 RRM 6. FT COMPBIAS 225 232 Poly-Glu. FT COMPBIAS 391 396 Poly-Glu. FT COMPBIAS 714 725 Poly-Glu. FT MOD_RES 174 174 Phosphoserine. FT MOD_RES 176 176 Phosphoserine. FT MOD_RES 180 180 Phosphoserine. FT MOD_RES 949 949 Phosphoserine. FT MOD_RES 951 951 Phosphoserine. FT MOD_RES 957 957 Phosphothreonine. FT VARIANT 602 602 Q -> E (in dbSNP:rs7299217). FT /FTId=VAR_059822. FT VARIANT 609 609 H -> R (in dbSNP:rs2290789). FT /FTId=VAR_023114. FT VARIANT 623 623 I -> T (in dbSNP:rs2290788). FT /FTId=VAR_023115. FT VARIANT 665 665 T -> A (in dbSNP:rs2290787). FT /FTId=VAR_023116. FT VARIANT 821 821 R -> G (in dbSNP:rs16943379). FT /FTId=VAR_057246. FT VARIANT 921 921 R -> Q (in dbSNP:rs2075387). FT /FTId=VAR_023117. FT CONFLICT 141 141 Q -> R (in Ref. 1; BAA31657). FT CONFLICT 259 259 K -> R (in Ref. 1; BAA31657 and 5; FT AAH06137/AAH04289). FT STRAND 295 299 FT HELIX 307 314 FT STRAND 320 326 FT STRAND 332 339 FT HELIX 343 351 FT STRAND 354 357 SQ SEQUENCE 960 AA; 107332 MW; 28B6F37B18D7B9B1 CRC64; MSRLIVKNLP NGMKEERFRQ LFAAFGTLTD CSLKFTKDGK FRKFGFIGFK SEEEAQKAQK HFNKSFIDTS RITVEFCKSF GDPAKPRAWS KHAQKPSQPK QPPKDSTTPE IKKDEKKKKV AGQLEKLKED TEFQEFLSVH QRRAQAATWA NDGLDAEPSK GKSKPASDYL NFDSDSGQES EEEGAGEDLE EEASLEPKAA VQKELSDMDY LKSKMVKAGS SSSSEEEESE DEAVHCDEGS EAEEEDSSAT PVLQERDSKG AGQEQGMPAG KKRPPEARAE TEKPANQKEP TTCHTVKLRG APFNVTEKNV MEFLAPLKPV AIRIVRNAHG NKTGYIFVDF SNEEEVKQAL KCNREYMGGR YIEVFREKNV PTTKGAPKNT TKSWQGRILG ENEEEEDLAE SGRLFVRNLP YTSTEEDLEK LFSKYGPLSE LHYPIDSLTK KPKGFAFITF MFPEHAVKAY SEVDGQVFQG RMLHVLPSTI KKEASEDASA LGSSSYKKKK EAQDKANSAS SHNWNTLFMG PNAVADAIAQ KYNATKSQVF DHETKGSVAV RVALGETQLV QEVRRFLIDN GVSLDSFSQA AAERSKTVIL VKNLPAGTLA AQLQETFGHF GSLGRVLLPE GGITAIVEFL EPLEARKAFR HLAYSKFHHV PLYLEWAPVG VFSSTAPQKK KLQDTPSEPM EKDPAEPETV PDGETPEDEN PTEEGADNSS AKMEEEEEEE EEEEESLPGC TLFIKNLNFD TTEEKLKEVF SKVGTVKSCS ISKKKNKAGV LLSMGFGFVE YRKPEQAQKA LKQLQGHVVD GHKLEVRISE RATKPAVTLA RKKQVPRKQT TSKILVRNIP FQAHSREIRE LFSTFGELKT VRLPKKMTGT GTHRGFGFVD FLTKQDAKRA FNALCHSTHL YGRRLVLEWA DSEVTLQALR RKTAAHFHEP PKKKRSVVLD EILEQLEGSD SDSEEQTLQL //